Detalles de la búsqueda
1.
Interferon inducible guanylate-binding protein 1 modulates the lipopolysaccharide-induced cytokines/chemokines and mitogen-activated protein kinases in macrophages.
Microbiol Immunol
; 68(5): 185-195, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462687
Mostrar más
Texto completo
Documentos relacionados
2.
Human anaerobic microbiome: a promising and innovative tool in cancer prevention and treatment by targeting pyruvate metabolism.
Cancer Immunol Immunother
; 72(12): 3919-3930, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882845
3.
Transferrin decorated PLGA encumbered moxifloxacin nanoparticles and in vitro cellular studies.
Drug Dev Ind Pharm
; 49(1): 129-138, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852720
4.
Interferon inducible guanylate binding protein 1 restricts the growth of Leishmania donovani by modulating the level of cytokines/chemokines and MAP kinases.
Microb Pathog
; 168: 105568, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35537595
5.
Silibinin-loaded chitosan-capped silver nanoparticles exhibit potent antimicrobial, antibiofilm, and anti-inflammatory activity against drug-resistant nosocomial pathogens.
J Biomater Sci Polym Ed
; : 1-23, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38787751
6.
Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease.
Microbiol Res
; 279: 127550, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016379
7.
Nano-immunomodulators: prospective applications to combat drug resistant bacterial infections and related complications.
J Biomater Sci Polym Ed
; 34(18): 2577-2597, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938026
8.
Staphylococcus aureus vaccine strategy: Promise and challenges.
Microbiol Res
; 271: 127362, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36958134
9.
Bilayer fixed-dose combination tablet for curcumin microparticles and piroxicam and in vitro evaluation.
Ther Deliv
; 2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36748662
10.
Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
J Immunol
; 183(1): 470-9, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19542458
11.
Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
Phytomedicine
; 24: 87-95, 2017 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28160866
12.
Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
PLoS One
; 9(9): e108556, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25268700
13.
Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.
PLoS One
; 9(1): e86073, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24475071
14.
Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis.
PLoS One
; 7(4): e35670, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22539989
Resultados
1 -
14
de 14
1
Próxima >
>>